RRM2 and cardiomyopathy: As predicted, RRM2 overexpression ameliorated DOX-induced cardiomyopathy, indicated by reduced pro-apoptotic and autophagy-related proteins (Figure 4C,D) and improved myofibrillar degeneration and disruption (Figure 4E).